Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...
New data from the PROMISE III trial show the LimFlow transcatheter deep venous arterialization system achieved over 80% amputation-free survival at six months in 'no-option' chronic limb-threatening ...
COLLEGE STATION, Texas (KBTX)- This segment on The Three was paid for and sponsored by Davis Vein & Vascular. Davis Vein & Vascular is now offering a procedure aimed at saving the limbs of patients ...
During limb salvage surgery, surgeons try to save as much of your limb as possible instead of removing the entire limb. It’s used to treat tumors in your arms or legs. Limb salvage surgery, also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results